Tribune Therapeutics AB

Series-A
tribunetx.com Biotech & Healthcare Stockholm, Sweden
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Mar 27, 2025
Investors 7 Backers
Decision Makers 5 Verified

About Tribune Therapeutics AB

Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Stockholm, Sweden
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website tribunetx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

  2. Capital Raise

    Seed announced

    fundraisingfox.com

Investors & Backers

7
HealthCap
Industrifonden
Innovestor
Inven2
Investinor
LifeArc Ventures
Novo Holdings

Funding History

2 Rounds
Series-A · Mar 27, 2025
Seed · Mar 26, 2025

Founders & Leadership

3

Jonas Hansson

Executive Chairman

Work email & phone locked Unlock →

Ole Kaasboell

Founder

Work email & phone locked Unlock →

Ole Kaasbøll

co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts